Metformin enhanced immune cell-mediated killing of cancer cells in vitro [40], consistent with our observation that Alisertib or genetic loss of function led NK cells effectively targeting GBM cells due to decreased levels of PD-L1 resulting from blocking AURKA. This evidence concerns the gene AURKA and cancer.